GPLG is one of the recognition sequences of the matrix metalloproteinase 2 (MMP-2), which is co-localized on the cell surface with the integrin αVβ3 receptor (Brooks et al., 1996) and is overexpressed in tumors, such as glioblastoma and malignant melanoma. Here, MMP2 is linked to melanoma.